British Journal of Haematology

Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion
pp. 503-503(1)
Authors: Lane, Steven W.; Fairbairn, David J.; McCarthy, Catherine; Nandini, Adayapalam; Perry-Keene, Joanna; Kennedy, Glen A.

Intramedullary aggregation and phagocytosis of neutrophils in chronic benign neutropenia of childhood
pp. 504-504(1)
Authors: Urban, Christian; Lackner, Herwig; Sovinz, Petra; Beham-Schmid, Christine

Acquired pure red cell aplasia: updated review of treatment
pp. 505-514(10)
Authors: Sawada, Kenichi; Fujishima, Naohito; Hirokawa, Makoto

Antiplatelet drugs
pp. 515-528(14)
Authors: De Meyer, Simon F.; Vanhoorelbeke, Karen; Broos, Katleen; Salles, Isabelle I.; Deckmyn, Hans

Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis
pp. 529-537(9)
Authors: Cavazzini, Francesco; Hernandez, Jose Angel; Gozzetti, Alessandro; Russo Rossi, Antonella; De Angeli, Cristiano; Tiseo, Ruana; Bardi, Antonella; Tammiso, Elisa; Crupi, Rosaria; Lenoci, Maria Pia; Forconi, Francesco; Lauria, Francesco; Marasca, Roberto; Maffei, Rossana; Torelli, Giuseppe; Gonzalez, Marcos; Martin-Jimenez, Patricia; Maria Hernandez, Jesus; Rigolin, Gian Matteo; Cuneo, Antonio

Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis
pp. 538-550(13)
Authors: Katzenberger, Tiemo; Kienle, Dirk; Stilgenbauer, Stephan; Höller, Sylvia; Schilling, Carolin; Mäder, Uwe; Puppe, Bernhard; Petzoldt, Celine; Sander, Sandrine; Bullinger, Lars; Stöcklein, Heike; Kalla, Jörg; Hartmann, Elena; Adam, Patrick; Ott, M. Michaela; Müller-Hermelink, Hans-Konrad; Rosenwald, Andreas; Ott, German

HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma
pp. 551-561(11)
Authors: Nimmanapalli, Ramadevi; Gerbino, Elvira; Dalton, William S.; Gandhi, Varsha; Alsina, Melissa

Gene expression profiling of diffuse large B-cell lymphoma supervised by CD21 expression
pp. 562-570(9)
Authors: Miyazaki, Kana; Yamaguchi, Motoko; Suguro, Miyuki; Choi, Woonyoung; Ji, Yuan; Xiao, Lianchun; Zhang, Wei; Ogawa, Shoko; Katayama, Naoyuki; Shiku, Hiroshi; Kobayashi, Tohru

BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia
pp. 571-582(12)
Authors: José-Enériz, Edurne San; Román-Gómez, José; Cordeu, Lucia; Ballestar, Esteban; Gárate, Leire; Andreu, Enrique J.; Isidro, Isabel; Guruceaga, Elizabeth; Jiménez-Velasco, Antonio; Heiniger, Anabel; Torres, Antonio; Calasanz, Maria José; Esteller, Manel; Gutiérrez, Norma C.; Rubio, Angel; Pérez-Roger, Ignacio; Agirre, Xabier; Prósper, Felipe

A modified version of galectin-9 induces cell cycle arrest and apoptosis of Burkitt and Hodgkin lymphoma cells
pp. 583-594(12)
Authors: Makishi, Shoko; Okudaira, Taeko; Ishikawa, Chie; Sawada, Shigeki; Watanabe, Toshiki; Hirashima, Mitsuomi; Sunakawa, Hajime; Mori, Naoki

Highly purified CD38⁺ sub-populations show no evidence of preferential clonal evolution despite having increased proliferative activity when compared with CD38⁻ sub-populations derived from the same chronic lymphocytic leukaemia patient
pp. 595-605(11)
Authors: Lin, Thet Thet; Hewamana, Saman; Ward, Rachel; Taylor, Hannah; Payne, Tammy; Pratt, Guy; Baird, Duncan; Fegan, Chris; Pepper, Chris

South Asian chronic lymphocytic leukaemia patients have more rapid disease progression in comparison to White patients
pp. 606-609(4)
Authors: Gunawardana, Chaminda; Austen, Belinda; Powell, Judith E.; Fegan, Christopher; Wandroo, Farooq; Jacobs, Abe; Pratt, Guy; Moss, Paul

Risk factors for early death in neonates with Down syndrome and transient leukaemia
pp. 610-615(6)
Authors: Muramatsu, Hideki; Kato, Koji; Watanabe, Nobuhiro; Matsumoto, Kimikazu; Nakamura, Tomohiko; Horikoshi, Yasuo; Mimaya, Junichi; Suzuki, Chizuko; Hayakawa, Masahiro; Kojima, Seiji

Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia
pp. 616-621(6)
Authors: Lönnerholm, Gudmar; Frost, Britt-Marie; Abrahamsson, Jonas; Behrendtz, Mikael; Castor, Anders; Forestier, Erik; Heyman, Mats; Uges, Donald R. A.; de Graaf, Siebold S. N.

Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythemia vera
pp. 622-626(5)
Authors: Cario, Holger; Schwarz, Klaus; Herter, Jan M.; Komrska, Vladimir; McMullin, Mary F.; Minkov, Milen; Niemeyer, Charlotte; Pospisilova, Dagmar; Reinhard, Harald; Debatin, Klaus-Michael; Pahl, Heike L.

CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation
pp. 627-637(11)
Authors: Banz, Yara; Beldi, Guido; Wu, Yan; Atkinson, Ben; Usheva, Anny; Robson, Simon C.

Antiphospholipid antibodies in adults with immune thrombocytopenic purpura
pp. 638-643(6)
Authors: Pierrot-Deseilligny Despujol, Carole; Michel, Marc; Khellaf, Mehdi; Gouault, Michèle; Intrator, Liliane; Bierling, Philippe; Godeau, Bertrand

IgG subclasses of anti-FVIII antibodies during immune tolerance induction in patients with hemophilia A
pp. 644-652(9)
Authors: van Helden, Pauline M. W.; van den Berg, H. Marijke; Gouw, Samantha C.; Kaijen, Paul H. P.; Zuurveld, Marleen G.; Mauser-Bunschoten, Evelien P.; Aalberse, Rob C.; Vidarsson, Gestur; Voorberg, Jan

Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia
pp. 653-656(4)
Authors: Ward, Alister C.; Gits, Judith; Majeed, Fidel; Aprikyan, Andrew A.; Lewis, Rowena S.; O'Sullivan, Lynda A.; Freedman, Melvin; Shigdar, Sarah; Touw, Ivo P.; Dale, David C.; Dror, Yigal

New mutations in C1GALT1C1 in individuals with Tn positive phenotype
pp. 657-667(11)
Authors: Karamatic Crew, Vanja; Singleton, Belinda K.; Green, Carole; Parsons, Stephen F.; Daniels, Geoff; Anstee, David J.

Management of paroxysmal cold haemoglobinuria: not only avoiding cold but also keeping warm
pp. 668-668(1)
Authors: Win, Nay; Roberts, David J.

Urinary hepcidin excretion in patients with myelodysplastic syndrome and myelofibrosis
pp. 669-671(3)
Authors: Winder, Asher; Lefkowitz, Rafi; Ghoti, Hussam; Leiba, Merav; Ganz, Tomas; Nemeth, Elizabeta; Rachmilewitz, Eliezer A.

Platelet factor 4-heparin complexes trigger immune responses independently of the MyD88 pathway
pp. 671-673(3)
Authors: Suvarna, Shayela; Qi, Rui; Hollingsworth, John W.; Arepally, Gowthami M.

Sequential tyrosine kinase inhibitor therapy: sustained disease remission in Philadelphia-positive erythroleukaemia
pp. 674-675(2)
Authors: Craig, Joanne; Walker, Katherine; Sales, Mark; Cunningham, Joan; Gelly, Keith; Pippard, Martin J.; Tauro, Sudhir

Successful reduced-intensity bone marrow transplantation in a patient with bone marrow failure associated with Seckel syndrome
pp. 675-676(2)
Authors: Rayburg, Melissa; Davies, Stella M.; Mehta, Parinda A.; Crockett, Michelle; Jodele, Sonata

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients
pp. 676-679(4)
Authors: Kouroupi, Eirini; Zoi, Katerina; Parquet, Nathalie; Zoi, Christine; Kiladjian, Jean-Jacques; Grigoraki, Vassiliki; Vainchenker, William; Lellouche, Franck; Marzac, Christophe; Schlageter, Marie-Hélène; Dosquet, Christine; Scott, Linda M.; Fenaux, Pierre; Loukopoulos, Dimitris; Chomienne, Christine; Cassinat, Bruno

Adherence to desferrioxamine and deferiprone and the impact of deferiprone co-prescription in thalassaemia major patients. Does the addition of deferiprone improve adherence?
pp. 679-680(2)
Authors: Kidson-Gerber, Giselle; Lindeman, Robert